PAPER Shang C, Sakurai K, Nihashi T, Arahata Y, Takeda A, Ishii K, Ishii K, Matsuda H, Ito K, Kato T, Toyama H, Nakamura A, BATON Study Group
SEARCH RESULTS
331007 RESULTS
PAPER Haskologlu IC, Erdag E, Sehirli AO, Uludag O, Abacioglu N
Beyond Conventional Therapies: Molecular Dynamics of Alzheimer's Treatment through CLOCK/BMAL1 Interactions.
Curr Alzheimer Res. 2024 Mar 19; PubMed: 38509675PAPER Zu L, Wang X, Liu P, Xie J, Zhang X, Liu W, Li Z, Zhang S, Li K, Giannetti A, Bi W, Chiavaioli F, Shi L, Guo T
Ultrasensitive and Multiple Biomarker Discrimination for Alzheimer's Disease via Plasmonic & Microfluidic Sensing Technologies.
Adv Sci (Weinh). 2024 Mar 20;:e2308783. PubMed: 38509587PAPER Kim JB, Kim SJ, So M, Kim DK, Noh HR, Kim BJ, Choi YR, Kim D, Koo H, Kim T, Woo HG, Park SM
Artificial intelligence-driven drug repositioning uncovers efavirenz as a modulator of α-synuclein propagation: Implications in Parkinson's disease.
Biomed Pharmacother. 2024 Mar 20;174:116442. PubMed: 38513596PAPER Mahapatra A, Newberry RW
Liquid-liquid phase separation of α-synuclein is highly sensitive to sequence complexity.
Protein Sci. 2024 Apr;33(4):e4951. PubMed: 38511533PAPER Walke G, Kumar R, Wittung-Stafshede P
Copper ion incorporation in α-synuclein amyloids.
Protein Sci. 2024 Apr;33(4):e4956. PubMed: 38511511PAPER Zhang D, Zhang W, Ming C, Gao X, Yuan H, Lin X, Mao X, Wang C, Guo X, Du Y, Shao L, Yang R, Lin Z, Wu X, Huang TY, Wang Z, Zhang YW, Xu H, Zhao Y
P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy.
Neuron. 2024 Mar 12; PubMed: 38513667PAPER Mychajliw C, Holz H, Minuth N, Dawidowsky K, Eschweiler GW, Metzger FG, Wortha F
Performance Differences of a Touch-Based Serial Reaction Time Task in Healthy Older Participants and Older Participants With Cognitive Impairment on a Tablet: Experimental Study.
JMIR Aging. 2024 Mar 21;7:e48265. PubMed: 38512340PAPER Wang B, Cui C, Chen Y, Liang Z
The mediating effect of 18F-FDG metabolism in right caudate between depressive symptoms and cognitive function in Alzheimer's disease.
Front Aging Neurosci. 2024;16:1328143. Epub 2024 Mar 6 PubMed: 38511197PAPER Medeiros D, McMurry K, Pfeiffer M, Newsome K, Testerman T, Graf J, Silver AC, Sacchetti P
Slowing Alzheimer's disease progression through probiotic supplementation.
Front Neurosci. 2024;18:1309075. Epub 2024 Mar 6 PubMed: 38510467PAPER Punzi M, Sestieri C, Picerni E, Chiarelli AM, Padulo C, Delli Pizzi A, Tullo MG, Tosoni A, Granzotto A, Della Penna S, Onofrj M, Ferretti A, Delli Pizzi S, Sensi SL, Alzheimer's Disease Neuroimaging Initiative
Atrophy of hippocampal subfields and amygdala nuclei in subjects with mild cognitive impairment progressing to Alzheimer's disease.
Heliyon. 2024 Mar 30;10(6):e27429. Epub 2024 Mar 8 PubMed: 38509925PAPER Jagust WJ, Mattay VS, Krainak DM, Wang SJ, Weidner LD, Hofling AA, Koo H, Hsieh P, Kuo PH, Farrar G, Marzella L
Quantitative Brain Amyloid PET.
J Nucl Med. 2024 Mar 21; PubMed: 38514082PAPER Gontrum EQ, Paolillo EW, Lee S, Diaz V, Ehrenberg A, Saloner R, Mundada NS, La Joie R, Rabinovici G, Kramer JH, Casaletto K
Neuropsychiatric profiles and cerebral amyloid burden in adults without dementia.
Dement Geriatr Cogn Disord. 2024 Mar 21; PubMed: 38513620PAPER Pak V, Adewale Q, Bzdok D, Dadar M, Zeighami Y, Iturria-Medina Y
Distinctive whole-brain cell types predict tissue damage patterns in thirteen neurodegenerative conditions.
Elife. 2024 Mar 21;12 PubMed: 38512130PAPER Wang Y, Liu Y, Wang Y, Bai P, Hallisey MR, Varela BL, Siewko A, Wang C, Xu Y
Development and Characterization of a Novel Carbon-11 Labeled Positron Emission Tomography Radiotracer for Neuroimaging of Sirtuin 1 with Benzoxazine-Based Compounds.
Drug Des Devel Ther. 2024;18:819-827. Epub 2024 Mar 15 PubMed: 38511202Current Filters
No filters selected